热诺斯基外体作为癌症中自媒介:最近的趋势和进展
Maryam Mojahedi1, Mohammad Reza Tohidkia1, Keyvan Kheyrolahzadeh1
1Research Center for Pharmaceutical Nanotechnology, Tabriz University of Medical Sciences, Tabriz, Iran.
European journal of pharmacology
|June 9, 2025
概括
自在癌症中具有双重作用,抑制早期的瘤,但促进已建立的癌症生长. 治疗性外体提供了一个有前途的方法,用于精确的癌症医学,通过准自.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 纳米医学是一种纳米医学.
背景情况:
- 自在癌症中表现出复杂的作用,同时作为瘤抑制剂和促进剂.
- 向自为增强化学疗法和放射治疗等常规癌症疗法的机会.
- 超神外体 (EXO) 正在成为癌症治疗精密医学的关键工具.
研究的目的:
- 探索自在癌症发展和进展中的双重作用.
- 为了研究神经外体在调节癌症治疗的自的潜力.
- 了解细胞沟通和免疫反应中的外体和自之间的相互作用.
主要方法:
- 关于癌症中自的当前文献的综述.
- 在精密瘤学中对超神体外体应用的分析.
- 在癌症生物学中探索EXO-自相互作用.
主要成果:
- 自在癌症发作中的情境依赖性作用与已确定的瘤生长相比.
- 作为诊断生物标志物和向药物递送系统,EXO具有潜力.
- EXO和自之间的相互作用影响癌症的进展和免疫调节.
结论:
- 针对自和神经外体之间的复杂关系对于开发新型癌症疗法至关重要.
- 解决EXO提取,货物装载和安全方面的挑战对于临床翻译至关重要.
- 对EXO介导的自调节的进一步研究可以导致改善癌症治疗策略和患者的治疗结果.
相关概念视频
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Autophagy
4.2K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.2K
Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K


